Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-047645

VP Finance/Prin Fin&Acct Offic acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John VP Finance/Prin Fin&Acct Offic 2024-04-23 Option exercise +30,000 $0.36 $10,800 84,030 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John VP Finance/Prin Fin&Acct Offic 2024-04-23 Option exercise · Stock option (right to buy) −30,000 120,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…